ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia

NCT04256148 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study is withdrawn due to the global impact of the COVID-19 pandemic.

Conditions

Warm Autoimmune Hemolytic Anemia

Interventions

BIOLOGICAL: ALXN1830
OTHER: Placebo

Sponsor

Alexion Pharmaceuticals, Inc.